Skip to main content

Table 2 Clinical outcomes of the endoscopic submucosal dissection induced ulcers

From: Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial

 

Vonoprazan group

n = 85

Lansoprazole group

n = 83

P-value

Healing of the artificial ulcer at 4 weeks, n (%)

17 (20.0)

14 (16.9)

0.60

Healing of the artificial ulcer at 8 weeks, n (%)

66 (77.6)

70 (84.3)

0.27

Median shrinkage rate of the artificial ulcer at 4 weeks, % (range)

96.3 (18.2–100)

95.1 (39.3–100)

0.68

Median shrinkage rate of the artificial ulcer at 8 weeks, % (range)

100 (92.7–100)

100 (89.3–100)

0.35

Complications

   

Delayed perforation, n (%)

1 (1)

0 (0)

1.00

Post-operative bleeding, n (%)

0 (0)

3 (4)

0.12